Alphavirus vectors, particularly those based on the replicon of Semliki Forest virus, have shown great potential as gene delivery vehicles for various applications in cancer gene therapy. The rapid production of high-titer recombinant SFV particles, which show impressive transduction rates in various mammalian cell lines, primary cultures and in vivo, results in high levels of transgene expression. Additionally, SFV vectors induce apoptosis in transduced host cells, which can further increase their efficiency in tumor therapy. Because of the broad host range some attempts to target the gene delivery have been engineered for Sindbis virus vectors, where IgG binding domains of protein A have been introduced into the envelope structure of the recombinant particles to allow attachment of virus to host cells through the interaction of protein A with monoclonal antibodies. SFV vectors have also been employed for the production of retrovirus-like particles for establishment of long-term gene expression. Tumor vaccine approaches have been taken by injection of SFV vectors as naked RNA molecules, DNA plasmids or recombinant particles to achieve both therapeutic and prophylactic efficacy. The continuous improvement of alphavirus vectors will further expand the application range in the future.
References
1.
LiljeströmP. and GaroffH.A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Bio/Technology9, 1356–1361 (1991).
2.
XiongC., LevisR., ShenP., RiceC. M., and HuangH. V.Science243, 1188–1191 (1989).
3.
DavisNL, BrownK. W., and JohnstonR E.R.E.In vitro synthesis of infectious venezuelan equine encephalitis virus RNA from a cDNA clone: Analysis of a viable deletion mutant. Virology171, 189–204 (1989).
4.
StraussJ. H., and StraussE. G.The alphaviruses: Gene expression, replication, and evolution. Microbiol. Rev.58, 491–562 (1994).
5.
LundstromK.Alphaviruses as tools in neurobiology and gene therapy. J. Receptor Signal Transduction Res.19, 673–686 (1999).
6.
LundstromK., RichardsJ. G., PinkJ. R., and JenckF.Efficient in vivo expression of reporter gene in rat brain after injection of recombinant repli cation-deficent Semiliki Forest virus. Gene Ther. Mol. Biol.3, 15–23 (1999).
7.
LundstromK., PralongW., and PralongJ-C.Anti-apoptotic effect of Bcl-2 overexpression in RIN cells infected with Semliki Forest virus. Apoptosis2, 189–191 (1997).
8.
LoimasS., WahlforsJ., and JänneJ.Herpes simplex virus thymidine kinase-green fluorescent protein fusion gene: New tool for gene transfer studies and gene therapy. Biotechniques24, 614–618 (1998).
9.
LoimasS., PasanenT., GomesA., BizarroS., MorganR. A., JänneJ., and WahlforsJ.Viral vectors carrying a marker-suicide fusion gene (TK-GFP) as tools for TK/GCV-mediated cancer gene therapy. Gene Ther. Mol. Biol.5, 165–174 (2000).
10.
LoimasS., ToppinenM-R., VisakorpiT., JänneJ., and WahlforsJ.Human prostate carcinoma cells as targets for herpes simplex virus thymi dine kinase-mediated suicide gene therapy. Cancer Gene Ther.8, 137–144 (2001).
11.
HardyP. A., MazziniM. J., SchweitzerC., LundstromK., and GlodeL.L.M.Recombinant Semliki forest virus infects and kills human prostate can cer cell lines and prostatic duct epithelial cells ex vivo. Int. J. Mol. Medicine5, 241–245 (2000).
12.
Asselin-PaturelC., LassauN., GuinebretiereJ-M., ZhangJ., GayF., BexF., HallezS., LeclereJ., PeronneauP., Mami-ChouaibF., and ChouaibS.Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonography. Gene Ther.6, 606–615 (1999).
13.
MurphyA., Morris-DownesM. M., SheahanB. J., and AtkinsG.Inhibition of human lung carcinoma cell growth by apoptosis induction using Semliki Forest virus recombinant particles. Gene Ther.7, 1477–1482 (2000).
14.
MurphyA., SheahanB. J., AtkinsG. J.Induction of aopotosis in Bcl-2 expressing rat prostate cancer cells using Semliki Forest vector. Ing. J. Cancer Vaccine94, 572–578 (2001).
15.
KlimpA. H., Van der VaartE., LansinkP. O., WithoffS., de VriesE. G., ScherphofG. L., WilschutJ., and DaemenT.Activation of peritoneal cells upon in vivo transfection with a recombinant alphavirus expressing GM-CSF. Gene Ther.8, 300–307 (2001).
16.
EhrengruberM. U., LundstromK., SchweitzerC., HeussC., SchlesingerS., and GähwilerB. H.Recombinant Semliki Forest virus and Sindbis virus efficiently infect neurons in hippocampal slice cultures. Proc. Natl. Acad. Sci. USA96, 7041–7046 (1999).
17.
OhnoK., SawaiK., IijimaY., LevinB., and MerueloD.Cell-specific targeting of Sindbis virus vectors displaying IgG-binding domains of protein A. Nat. Biotech.15, 763–767 (1997).
18.
SawaiK., and MerueloD.Cell-specific transfection of choriocarcinoma cells by using Sindbis virus hCG expressing chimeric vector. Biochem. Biophys. Res. Comm.248, 315–323 (1998).
19.
LundstromK.Alphavirus vectors: Applications for DNA vaccine production and gene expression. Intervirology43, 247–257 (2000).
20.
ZhouX., BerglundP., ZhaoH., LiljeströmP., and JondalM.Generation of cytotoxic and humoral immune responses by non-replicative recombinant Semliki Forest virus. Proc. Natl. Acad. Sci. USA92, 3009–3013 (1995).
21.
SchlesingerS., and DubenskyT. W.Alphavirus vectors for gene expression and vaccines. Curr. Opin. Biotechnol.10, 434–439 (1999).
22.
HeveyM., NegleyD., PushkoP., SmithJ., and SchmaljohnA.Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and non human primates. Virology251, 28–37 (1998).
23.
YingH., ZaksT. Z., WangR-F., IrvineK. R., KammulaU. S., MarincolaF. M., LeitnerW. W., and RestifoN. P.Cancer therapy using a self-replicating RNA vaccine. Nat. Med.5, 823–827 (1999).
24.
ColmeneroP., LiljeströmP., and JondalM.Induction of P815 tumor immunity by recombinant Semliki Forest virus expressing the P1Agene. Gene Ther.6, 1728–1733 (1999).
25.
DaemenT., PriesF., BungenerL., KraakM., RegtsJ., and WilschutJ.Genetic immunization against cervical carcinoma: Induction of cytotoxic lymphocyte activity with a recombinant alphavirus vector expressing human papillomavirus type 16 E6 and E7. Gene Ther.7, 1859–1866 (2000).
26.
LiK-J., and GaroffH.Production of infectious recombinant Moloney murine leukemia virus particles in BHK cells using Semliki Forest virus-derived RNA expression vectors. Proc. Natl. Acad. Sci. USA93, 11658–111663 (1996).
27.
LiK-J., and GaroffH.Packaging of intron-containing genes into retro virus vectors by alphavirus vectors. Proc. Natl. Acad. Sci. USA95, 3650–3654 (1998).
28.
WahlforsJ. J., XanthopoulusK. G., and MorganR. A.Production of mini gene-containing retroviral vectors using an alphavirus/retrovirus hybrid vec tor system. Hum. Gene Ther.10, 1197–1206 (1999).
29.
LebedevaI., FujitaK., NihraneA., and SilverJ.Infectious particles derived from Semliki Forest virus vectors encoding murine leukemia virus envelopes. J. Virol.71, 7061–7067 (1997).
30.
AgapovE. V., FrolovI., LindenbachB. D., PragaiB. M., SchlesingerS., and RiceC. M.Noncytopathic Sindbis virus RNA vectors for heterologous gene expression. Proc. Natl. Acad. Sci. USA95, 12989–12994 (1998).
31.
LundstromK., SchweitzerC., RichardsJ. G., EhreengruberM. U., JenckF., and MülhardtC.Semliki Forest virus vectors for in vitro and in vivo applications. Gene Ther. Mol. Biol.4, 23–31 (1999).
32.
LundstromK., RotmannD., HermannD., SchneiderE. M., and EhrengruberM. U.Novel mutant Semliki Forest virus vectors: Gene expression and localization studies in neuronal cells. Histochem. Cell. Biol.115, 83–91 (2001).
33.
PerriS., DriverD. A., GardnerJ. P., SherrillS., BelliB. A., DubenskiT. W., and PoloJ. M.Replicon vectors derived from Sindbis virus and Semliki forest virus that establish persistent replication in host cells. J. Virol.74, 9802–9807 (2000).
34.
TuittilaM. T., SantagatiM. G., RöyttäM., MäättäJ. A., and HinkkanenA. E.Replicase complex genes of Semliki Forest virus confer lethal neu rovirulence. J. Virol.74, 4579–4589 (2000).
35.
BerglundP., SjöbergM., GaroffH., AtkinsG. J., SheahanB. J., and LiljeströmP.Semliki Forest virus expression system: Production of conditionally infectious recombinant particles. Bio/Technology11, 916–920 (1993).
36.
SmerdouC., and LiljeströmP.Two-helper RNA system for production of recombinant Semliki forest virus particles. J. Virol.73, 1092–1098 (1999).
37.
PoloJ. M., BelliB. A., DriverD. A., FrolovI., SherrillS., HariharanM. J., TownsendK., PerriS., MentoS. J. D. J.JollyD. J., and ChangS.M.W.Stable alphavirus packaging cell lines for Sindbis virus and Semliki Forest virus-derived vectors. Proc. Natl. Acad. Sci. USA96, 4598–4603 (1999).
